Abstract: The present disclosure is directed to liquid boron compounds for use in scintillation. The present disclosure further relates to liquid boron compounds for admixture to plastic and liquid scintillators.

Abstract: The present disclosure is directed to liquid boron compounds for use in scintillation. The present disclosure further relates to liquid boron compounds for admixture to plastic and liquid scintillators.

Abstract: The present disclosure relates to a system and method of providing water management and utilization during the process of dewatering and retorting of oil shale. More specifically, the process described relates to co-producing potable and non-potable water, for various uses, during the extraction of petroleum from shale oil deposits. Generally, the process allows the production of multiple streams of waters or varying salinity and pressures at least one of which is of high enough pressure for reinsertion into geological formations or reservoirs, and another which may supply a potable water source. In one embodiment, the high pressure required for reinserting the non-potable water into geological formation or reservoirs may be utilized for producing the potable water supply. In another embodiment, the non-potable water supply may also be used for entraining and sequestering undesired emissions, such as CO2.

Abstract: The invention provides methods of producing composite polymers by combining fillers with polymers in the presence of preformed high molecular weight polymer. Monomer polymerization can be initiated through the addition of initiators or by reactive chemical groups on the surface of the fibers. The composite materials formed possess superior mechanical properties compared to similar polymer composites made by either purely mechanical mixing or solely polymerization of monomers in the presence of the fillers.

Abstract: A novel compound having antibacterial activity according to the the formula ##STR1## The compound of the present invention may be prepared from (9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido [3,2,1-ij]-1,3,4-benzadiazine-6-carboxylic acid by treatment with an oxidizing agent, such as hydrogen peroxide in the presence of an aqueous inorganic base. Additionally, there are provided methods for treating animals, including humans, suffering from bacterial infections.

Abstract: Novel compounds of formula (I): ##STR1## wherein R.sup.1 is hydrogen or optionally protected hydroxy; R.sup.2 is alkoxy, optionally protected hydroxy, oxo or optionally O-substituted oximino; R.sup.3 is hydrogen, optionally protected hydroxy,or a group 4'-(.alpha.-L-oleandrosyl)-.alpha.-L-oleandrosyloxy or .alpha.-L-oleandrosyloxy wherein the terminal hydroxy group is optionally protected; R.sup.4, R.sup.5, R.sup.6 and R.sup.7 are the same or different and each is hydrogen or an organic radical; and R.sup.8 is an optionally substituted amino or imino group such as optionally O-substituted oxyimino, optionally N-substituted hydrazone, or optionally N-substituted semicarbazone; are useful in the treatment of helminthiasis in humans and animals.

Abstract: Compounds of formula (I): ##STR1## wherein R.sup.1 is hydrogen or methyl, R.sup.2 is hydrogen or (E)-2-methyl 2-butenoyloxy, and R.sup.3 is hydrogen or hydroxy, with the proviso that when R.sup.3 is hydrogen, R.sup.1 and R.sup.2 are both hydrogen, and when R.sup.2 is (E)-2-methyl 2-butenoyloxy, R.sup.1 is methyl; the compound of formula (II): ##STR2## and the compound of formula (III): ##STR3## are obtainable by the fermentation of Streptomyces E225 NCIB 12310 or Streptomyces E225B NCIB 12509. The compounds have anthelmintic utility.